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Summary 
A large body of data indicate that antibody class switching is directed by cytokines by inducing 
or  repressing  transcription  from  unrearranged,  or  germline,  C.  genes.  Interleukin  4  (IL-4) 
induces transcription of the germline Ce genes in activated B cells and subsequently, cells in 
this population will undergo switch recombination to immunoglobulin E.  Furthermore,  the 
data suggest that transcription of germline Ce genes is required for class switching. In this paper 
we define DNA elements required for induction of transcription of the germline Ce genes by 
IL-4. To do this, segments of DNA from the 5' flank of the initiation sites for germline e RNA 
were ligated to a luciferase reporter gene and transfected into two mouse B cell lines, one of 
which can be induced to switch to IgE. By analysis of a series  of 5' deletion constructs and 
linker-scanning mutations, we demonstrate that a 46-bp segment (residing at  - 126/- 79 relative 
to the first RNA initiation site) contains an IL-4 responsive region. By electrophoretic mobility 
shift assays, we find that this segment binds three transcription factors: the recently described 
NF-IL4, one or more members of the C/EBP family of transcription factors, and NF-gB/p50. 
Mutation of any of the binding sites for these three factors abolishes or reduces IL-4 inducibility 
of the e promoter. A 27-bp segment within this IL-4 response region containing binding sites 
for NF-IL4 and a C/EBP factor is sufficient to transfer IL-4 inducibility to a minimal c-los promoter. 
A 
tibody class switching is effected by a DNA recombi- 
nation event that results in the substitution of one Ig 
heavy chain  constant  region  (C.)  gene for  another,  thus 
changing the C. region and thereby the effector function of 
the antibody, but keeping the antigen binding specificity un- 
changed. The specificity of class  switching is regulated by 
cytokines that direct switching by inducing or repressing tran- 
scription from unrearranged or germline C.  genes before 
switch recombination to the same C~ gene (1-7).  For ex- 
ample, a large body of data indicate that IL-4 induces tran- 
scription of the germline Ce gene in B cells activated by poly- 
clonal  activators,  e.g.,  LPS,  EBV  infection or  anti-CD40 
antibody, and that subsequently cells in this population will 
undergo switch recombination to the Ce gene, thereby al- 
lowing expression of IgE (7-11). Furthermore, it has recently 
been shown that if a DNA segment which contains the pro- 
moter and first exon (I, or germline exon) of the germline 
transcript is deleted, switching does not occur on that chro- 
mosome (5, 6,  12).  Although the sequences necessary and 
suf~cient for switching have not been defined, these gene 
knockout experiments indicate that transcription of germ- 
line transcripts is probably necessary for switching. There- 
fore, it is important to understand how transcription of un- 
rearranged  C,  genes is regulated. 
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A map of the mouse germline e DNA segment and tran- 
script is shown (see Fig.  1 A). The DNA sequences which 
regulate transcription of the mouse and human germline 
RNAs are currently being studied. Initial characterizations 
of DNA sequences which regulate induction by IL-4 have 
been published (13-15). In this report we characterize an ad- 
ditional  IL-4  responsive region  (IL-4RR) 1 in  the  mouse 
germline e promoter that overlaps with the previously charac- 
terized IL-4RR of the human germline e promoter (14). This 
e IL-4RR resides within a DNA sequence highly conserved 
between human and mouse and also has elements similar to 
those within an IL-4RR within the promoter for mouse germ- 
line ~1  transcripts  (16,  17). 
Materials and Methods 
Cell Lines.  Two mouse B lymphoma cell lines were used in 
this study: 22A10, a clone of the slgM + 1.29/z B cell lymphoma 
line  (18, 19) and M12.4.1,  an  Ig-negative,  class II §  HGPRT- 
1 Abbreviations used in this  paper CAT, chloramphenicol acetyl transferase; 
DTT, dithiothreitol; EMSA, electrophoretic mobility  shift assay; IL-4RR, 
IL-4 response region; mt, mutant. 
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(Columbia University, New York). 
Cell Culture.  22A10 cells were cultured as described for 1.29/~ 
cells (21). M12.4.1  cells were cultured at 37~  in an atmosphere 
of 5% CO2 in RPMI 1640 medium supplemented  with 10% FCS 
(Hyclone Laboratories, Logan, UT), 50/~M 2-ME, 0.1 mM nones- 
sential  amino acids, 1 mM sodium pyruvate, 2 mM t-glutamine, 
200 U/ml penicillin,  200 mg/ml streptomycin, and 0.1  mg/ml 
kanamycin sulfate. Cells were treated with murine rlL-4 (a gift from 
Dr. Steven Gillis, Immunex Corp., Seattle,  WA and the Sterling 
Research  Group, Malvern, PA) at 1,000 U/ml, unless  otherwise 
specified. In initial experiments, LPS (055:B5; Sigma Chemical Co., 
St. Louis,  MO) dissolved in RPMI,  was added  at 25 #g/ml of 
culture. 
Splenic B Cell Cultures.  Splenic B cells were purified and cul- 
tured as described  (22), except total B cells were used rather than 
only small B cells, and cells were cultured for 12 h with IL-4 at 
1,000 U/ml and LPS at 25/~g/ml,  as indicated. 
Isolation of RNA and RNA Blot Analysis.  Total cell RNA was 
prepared by the guanidinium isothiocyanate-CsC1 method (23) and 
RNA blots were prepared and hybridized as described (21). Quan- 
titation of hybridization was performed by densitometry on a Be- 
tascope 603 blot analyzer (Betagen, Waltham, MA). The Ce probe 
was a 2.1-kb BamHI/HindlII genomic DNA fragment (24). Hy- 
bridization to a GAPDH probe (25) or densitometry of 18S rRNA 
in photos of ethidinm bromide-stained agarose gels was used to 
normalize the difference in loading. 
RNase Protection Assay.  To determine the initiation site of germ- 
line e RNA, RNase protection assays were performed (26). Total 
cell RNA was prepared from 22A10 cells induced with an IL-4-con- 
taining supernatant from X63AgS-653-IL-4 for 48 h (27). The X63 
supernatant was titrated for germline e RNA induction and used 
at an optimal dose. The RNase protection probe was transcribed 
from a 512-bp HinclI/PstI genomic DNA fragment encompassing 
the Ie exon (28, 29) and cloned in Bluescript KS-. The plasmid 
was linearized with HinclI and transcribed in vitro with T7 poly- 
merase. 100 #g of total cell RNA was incubated with 250,000 cpm 
of the labeled P,  NA probe in a 30-/,1 volume containing 80% for- 
mamide, 40 mM Pipes, pH 6.4, 400 mM NaC1, and 1 mM EDTA 
at 80~  for 10 min, and then hybridized overnight at the indicated 
temperatures. Unhybridized RNA was digested at room tempera- 
ture for 90 min in  10 mM Tris, pH  7.4,  5 mM EDTA, pH  7, 
300 mM NaC1,  2/~g/ml RNase T1 (Sigma  Chemial Co.), and 
40 #g/ml RNase A (Sigma Chemical Co.). The hybridized RNA 
was recovered and electrophoresed on an 8-M urea sequencing gel 
alongside  a DNA sequencing ladder. 
Sequences of Oligonucleotides.  Lowercase letters are nucleotides 
added to create restriction enzyme sites and are not in the e pro- 
moter sequence,  e promoter oligonucleotides are: A-1 (32 met): 
5' gatccTGCCTTAGTCAACTTCCCAAGAACAGA 3'; A-2 (32 
met):  5'  gatcTCTGTTCTTGGGAAGTTGACTAAGGCAG 3'; 
Amt13-1  (31 mer): 5' gatccTGCCCCTCGAGGTTCCCAAGAA- 
CAGA 3'; Amt13-2 (31 mer): 5' gatcTCTGTTCTTGGGAACCT- 
CGAGGGGCAG 3'; Amt20-1 (32 mer): 5' gatccTGCCTTAGTC- 
AACTTCCCCCTCGAGGA 3'; Amt20-2 (32 mer): 5' gatcTC- 
CTCGAGGGGGAAGTTGACTAAGGCAG 3'; B-1 (19 mer): 5' 
gatccAAGGGAACTTCCAA 3'; B-2 (19 mer): 5' gatcT'I'GGAAGT- 
TCCCTTG 3'; Bmt27-1 (19 met): 5' gatccAAGGGCCTCGAGGA 
3'; Bmt27-2 (19 met): 5' gatcTCCTCGAGGCCCTTG 3'; C-1 (16 
met): 5' gatcCCCAAGAACAGA 3'; C-2 (16 met): 5' gatcTCTGT- 
TCTTGGG 3'; D-1 (19 mer): 5' gatccTTCCCAAGAACAGA 3'; 
D-2 (19 mer): 5' gatcTCTGTTCTTGGGAAG 3'; E-1 (18 mer): 
5' gatCCTTAGTCAACTTCA Y; E-2 (18 mer): 5' gatctGAAGTT- 
GACTAAG 3'; 5'e (- 788/- 733) (28 met): 5'ttagatctGACCTGC- 
AGCTGAGACAGAC 3'; and 3'e (+33/+53) (28 mer): 5' ttagat- 
ctTGTGCAGGCTCCCAGGCGTT 3'.  Non e promoter oligo- 
nucleotides are:  NFKB1 (27 mer): 5' CAACGGCAGGGGAAT- 
TCCCCTCTCCTT 3'; NI~B2  (27 met): 5' AAGGAGAGGG- 
GAATTCCCCTGCCGTTG 3'; Luc (+ 79/+ 96) primer (18 mer): 
5'GGCCCGC~GCCATTCTAT 3' (30); Fos (-25/-8) primer (18 
met): 5'GGCGCCTCAGCTGGCGCC 3' (31); and pXP2 poly- 
linker primer (17 mer): 5' AGATCCAAGCTTGTCGA 3'. Oligo- 
nucleotides were obtained from the University of Massachusetts 
Medical  School nucleic acid  facility,  Operon Technologies  Inc. 
(Alameda,  CA),  or DNA International (Woodlands,  TX). 
￿9 Promoter-Luciferase  Plasmids.  To create the 5' deletion constructs 
of the germline e promoter, a series of fragments containing var- 
ious lengths of the promoter segment were ligated into the plasmid 
pXP2, which has a polylinker but not a promoter upstream of the 
luciferase (Luc) reporter gene (32). The 3' border of these promoter 
fragments was created by PCR amplification of genomic e DNA, 
using the primers, 3'e (+33/+53 relative to the first start site) and 
5' e (-788/-773).  Nucleotide  +53 is within the Ie exon and is 
located 5' to the potential protein synthesis initiation codon at +65. 
The 5' borders were created by restriction enzyme digestion at 
BamHI (1.8-kb promoter) or BgllI (1.2-kb promoter), cloned into 
the BgllI site of pXP2, or by digestion with BstXI (640-bp pro- 
moter), HinclI (115-bp promoter), or AvrlI (15-bp promoter), and 
cloned into pXP2 digested with Sinai and BgllI. BstXI digestion 
followed by Ba131 digestion created additional smaller promoters 
that were cloned into pXP2 digested with SmaI and BgllI. The 
nucleotide sequences of all plasmids  having 640 bp or less of the 
promoter were verified by sequencing from the 5' direction using 
a primer complementary to the polylinker ofpXP2 (pXP2 primer) 
and also from the 3' direction, using the Luc primer, extending 
as far as possible. 
Linker-scanning Mutations.  8-bp Xho linker substitutions were 
introduced into the full-length promoter-luciferase reporter con- 
struct,  -162Luc, by using Bal31 to generate a nested set of 5' and 
3' deletion mutants, bounded by XhoI linker.  The deletion end 
points were determined by nucleotide sequencing.  5' and 3' dele- 
tion clones with matching end points were chosen as best as pos- 
sible to attempt to preserve the length of the wild-type promoter. 
Ligation of a BamHI (in polylinker)/XhoI fragment from a Y de- 
letion clone into a 5' deletion plasmid digested with BamHI and 
Xhol resulted in the regeneration of an approximately full-length 
promoter (in most cases) containing an 8-bp XhoI linker substitu- 
tion. All constructs were sequenced  across the sites of mutation 
using the pXP2 or Luc primers. 
pFL Reporter Plasraids.  Plasmid pFL contains the mouse c-Fos 
71-bp promoter segment from pfosCAT (33) (given by M. Lenardo, 
National Institutes of Health, Bethesda, MD) ligated 5' to the luci- 
ferase gene (34). Double-strand oligonucleotides containing BamHI 
sticky ends at the 5' end and BglII sticky ends at the 3' end were 
phosphorylated with 3,-[32p]ATP with T4 polynucleotide kinase 
at 1 U//~I (Boehringer Mannheim, Indianapolis,  IN), 2% wt/vol 
PEG 8000,  75 ng//~l BSA, and 1 mM ATP at 37~  for 30 rain. 
The phosphoryhted oligonucleotides were multimerized and ligated 
into the BamHI site of plasmid pFL. Recombinant clones  were 
screened by PCR amplification using the same e oligonucleotides 
as primers individually in combination with a primer complemen- 
tary to the c-Fos promoter. PCR products obtained using the top 
strand oligonucleotides indicated that the insert was in the correct 
orientation whereas PCR products obtained using the bottom strand 
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tion. Insert-containing clones were sequenced  using the Fos primer 
to confirm the number of multimers, their orientations, and the 
fidelity of the BamHI and BgllI restriction sites. 
DNA Sequencing.  Nucleotide sequences of  CsCl-purified or of 
mini-preparations ofphsmids were determined  by the dideoxy  chain 
termination method using Sequenase Version 2 kits (United States 
Biochemical Corp., Clevdand, OH). 
Transfection.  Transfection was  performed by dectroporation 
using Ceil ZaplI (Anderson Electronics, Brookline, MA). Briefly, 
RPMI 1640 was used to wash and resuspend an appropriate number 
of cells. 50  x  10  ~ ceils was the maximum transfected in 1 ml. In 
the experiments involving transfection of the 5' deletion constructs 
and the linker-scanning mutations, the internal control plasmid 
pSV2CAT (35) was added to the resuspended cells, mixed well, 
and 0.9 ml of the call mixture was pipetted into sterile cuvettes. 
CsCl-purified plasmid DNAs were added in a vohme of 100 #1 
to the cuvettes. The ceils were electroporated at 1250 #F/300 V, 
rested at room temperature for 10 min, and pipetted into complete 
medium at "~0.25 x  l& ceUs/ml. After addition of inducers, cells 
were incubated for 8-18 h and then assayed  for luciferase  or chlor- 
amphenicol acetyl transferase (CAT) activity. 
Luciferase Assays.  Luciferase  assays  were performed as described 
(36). Cells were washed in PBS, transferred to Eppendorf tubes, 
and lysed in 200 #1 Triton X-100 lysis buffer (1% Triton X-100, 
25 mM glycylglycine, pH 7.8 [Sigma Chemical Co.]),  15 mM 
MgSO~, 4 mM EGTA, and 1 mM dithiothreitol [DTT]) at room 
temperature. The reaction mixture contained 100 #1 cell lysate, 
350/~1 luciferase assay buffer  (25  mM  glycylglycine, pH  7.8, 
15 mM MgSO4, 4 mM EGTA, 15 mM KH2PO4, 2 mM ATP, and 
1.27 mM DTT), and 100/~1 of I mM luciferin  (Analytical  Lumines- 
cence Laboratory, San Diego, CA) dissolved  in distilled H20. The 
level of luciferase activity was determined with a Monolight 2010 
luminometer (Analytical  Luminescence  Laboratory) using plasmid 
pSV2Luc (34) as positive control. The values obtained from mock 
transfected or lysis buffer control were subtracted as background. 
CAT Assays.  The activity of cotransfected pSV2CAT was as- 
sayed to control for transfection efficiency  by the diffusion-based 
assay (37). 50 #1 ofceU lysates was heated at 70~  for 10 min be- 
fore mixing with 200 #I of 120 mM Tris, pH 7.8, 1 mM chloram- 
phenicol (Sigma Chemical Co.),  and 0.1  #Ci [H3]-acetyl CoA 
(200 mCi/mmol) (DuPont NEN Research Products, Wilmington, 
DE). The reaction mixture was added to a scintillation vial and 
5 ml of Econofluor (DuPont NEN Research'Products) was over- 
laid. The acetylated chloramphenicol was measured at the end of 
a 3-h incubation at 37~ 
Oligonucleotide Probes for Electrophoretic Mobility  Shift  Assay. 
Double-stranded oligonudentides were generated by annealing a 
complementary  pair of oligonucleotides.  The reaction mixture con- 
rained 100 ng/#l of  each oligonucleotide  in 100 mM NaCI, 10 mM 
Tris-HC1, pH 8, and 1 mM EDTA. The DNA was incubated at 
95~  for 10 min to disrupt secondary structures and incubated at 
10~  bdow the melting temperature for 1 h and then slowly  cooled 
to room temperature to anneal. The annealed  oligonucleotides  were 
ethanol precipitated and purified on a 12% polyacrylamide gal. 
Double-stranded oligonucleotides  were 3' endlabded with Khnow 
enzyme and ol[~2P]dCTP (3,000 Ci/mmol) to 5  x  10  s cpm/#g, 
and gel purified as above. 
Preparation of  Nuclear Extracts.  For small scale  preparations, the 
method ofSchreiber et al. (38) and for large scale preparations that 
of Dignam et al. (39), as modified by Boothby et al. (40) were 
used. Several protease inhibitors were added to all solutions just 
before use: 0.5 mM DTT, 0.5 mM PMSF, aprotinin (2 #g/ml), 
chymostatin (25 #g/ml), and leupeptin (10 #g/ml) (Boehringer 
Mannheim). Protein concentration was determined using the Brad- 
ford assay (Bin-Red Laboratories, Richmond,  CA). 
Electrophoretic  Mobility Shift Assay.  DNA binding reactions  were 
performed in 20-#1 reaction volumes containing 0.1 ng (30,000 
cpm) labeled DNA probe, 2-5 #g nuclear extracts, 2-4 #g poly 
(dI-dC) (Pharmacia, Piscataway,  NJ), 10% vol/vol glycerol,  50 mM 
KC1, 0.1 mM EDTA, 0.005% NP 40, 1 mM DTT, and 12.5 mM 
Hepes, pH 7.5. The amount of probe, poly (dI-dC), nuclear ex- 
tract, and KC1 concentration used was optimized for each frag- 
ment. The reaction mixture was incubated at room temperature 
for 30 rain and then loaded onto a 4-6% native polyacrylamide 
gel. All gels were electrophoresed  in recirculating  0.5 x TBE buffer 
at 100 V for 2-3 h. Supershift  experiments  were  performed  by adding 
1 #1 of antiserum in a 20-#1 binding reaction volume. 
Results 
Induction  of Germline  ￿9  Transcripts in  Two Mouse  B  Cell 
Lines.  For these studies, we used two B lymphoma cell lines 
that inducibly express germline e RNA. The 1.29#  mouse 
B lymphoma expresses surface IgM and can be induced to 
undergo  class  switching to  IgA by treatment with LPS. 
Switching can be increased by treatment with TGF-/8, which 
increases transcription from the unrearranged Co~ genes. 1.29# 
cells will switch to IgE expression  if treated with IL-4 plus 
LPS, although switching to IgE is about 100 times less fre- 
quent than optimal switching to IgA. The maximal frequency 
of cells expressing IgE (both cytoplasmic and surface expres- 
sion)  at day 5 after induction is ,x,0.1%, but this level can 
increase by day 7 to ",0.5% (18, and data not shown). 1.29# 
cells synthesize gerrnline e transcripts constitutively, and this 
can be further increased  5-20-fold by treatment with IL-4 
(Fig. 1 B, left) (2). Addition of LPS does not further increase 
the level of transcripts.  The other B cell lymphoma used for 
these studies is M12.4.1, a dass II +, sIg-negative variant that 
was derived from the M12 B lymphoma (20). M12.4.1  cells 
do not express germline e transcripts constitutively, but germ- 
line e transcripts can be induced by treatment with IL-4 plus 
LPS (Fig.  1 B, right)  (13). Unlike,  1.29#,  IL-4 alone does 
not induce detectible germline e transcripts in M12.4.1 cells. 
To begin to characterize DNA sequences that regulate tran- 
scription of germline e KNA, we verified by a RNase pro- 
tection assay the initiation sites of transcription of germline 
e KNA that were previously determined in 18-81A20 cells 
by Rothman et al. (28). RNA from IL-4-treated 1.29# cells 
was hybridized with a radioactive KNA probe transcribed 
from a 512-bp HindI/PstI e genomic DNA fragment, digested 
with RNase, and the products were dectrophoresed on a DNA 
sequencing gel Three protected fragments of 118, 100, and 
90 nucleotides were detected, which were not detected when 
the probe was hybridized with yeast RNA (Pig.  1 C). As- 
suming that the Ie splice donor defined previously by anal- 
ysis of cloned germline e cDNA from 18-81A20 cells is also 
used in 1.29# cells, we identified three transcription start sites 
very near the duster of initiation sites previously identified 
(~8).  The first is located six nucleotides 5' to the most 5' 
183  Delphin  and Stavnezer Figure  1.  Structure  of the mouse Ig heavy chain germline ~ gene and e transcript.  (A)  Restriction  map of unrearranged Ce gene and germline 
transcript with location of exons and switch region (Se) marked.  (/3) Blots containing total cell KNA from 1.29# (left) and M12.4.1 (right)  cells 
that had been cultured for 2 d, as indicated, with medium alone, IL-4 (2,000 U/ml), LPS (25 #g/ml), or with both II:4 and LPS, hybridized with 
Ce probe. (C) Products of an RNase protection  experiment  using a KNA probe transcribed from the 512-bp HinclI/PstI genomic DNA fragment 
encompassing the Ie, hybridized with total cell KNA from 1.29# cells induced with X63-I1:4 supernatant  at an optimal dose. Hybridization was 
at 42~  (two left lanes) or at 40~  (two right lanes). Three RNase  resistant bands of the indicated lengths (determined by alignment with a DNA 
sequencing ladder) are detected on the DNA sequencing gel, and the positions of the corresponding RNA initiation sites are indicated on the sequence 
of the promoter-IE-Luc construct in Fig. 2 A. We were unable to detect any band corresponding  to a start site at  -123, relative to our first start 
site, which was detected in 1.29# cells by primer extension experiments (53). 
site identified in  18-81A20.  The  start  sites  are indicated by 
arrows on the sequence of the promoter in Fig.  2 A.  The 
nudeotide positions referred to in this manuscript are all given 
relative to  the first  KNA initiation  site in  1.29# cells. 
Transient Transfection ~f  Luciferase Reporter Plasmids Containing 
Various Lengths of 5' Flanking Region from the Germline ￿9  Seg- 
ment.  To identify DNA segments necessary for regulation 
of transcription  of germline  e  RNA,  a series  of luciferase 
reporter plasmids containing various lengths of the 5' flank 
of the IE exon were prepared,  varying from having  1.8 kb 
to only 15 bp of 5' flanking sequences. The e promoter seg- 
ment present  in  the plasmid named  -162Luc is shown in 
Fig. 2 A. The plasmids were transiently transfected into 1.29# 
or M12.4.1 cells. Optimum luciferase activity was obtained 
when cells were harvested 12 h after transfection. An internal 
control CAT plasmid driven by a SV40 promoter/enhancer 
(pSV2CAT)  was used to correct  for transfection  effidency 
when comparing the basal activity of different plasmids.  Max- 
imal basal expression is not affected much by deletion of the 
5' flanking segment to  -127 relative to the KNA initiation 
sites, but further deletion reduces basal expression in both 
1.29#  and  M12.4.1  cell  lines  (Fig.  3,  A  and  B:  compare 
constructs  -  162LUC,  - 127LUC,  - 115LUC; and data not 
shown). 
To test whether  expression of these promoter-luciferase 
plasmids could be induced by IL-4, cells were divided after 
transfection into two more more aliquots and treated with 
recombinant mouse IL-4 for various times. Optimal responses 
were obtained with a dose of 240 ng/ml, which is equivalent 
to 2,500 U  IL-4/ml, and we routinely used 1,000 U/m1. The 
IL-4 inducibility of plasmids with the longest 5' flanks, having 
1.8 and 1.2 kb of e promoter segment, is two to four times 
less than  plasmids  having  from 640 to  162 bp of 5' flank, 
which are approximately equivalently  inducible by IL-4: eight- 
fold in 1.29# and threefold in M12.4.1  cells.  Deletion past 
-  162 reduces inducibility of the luciferase plasmids in both 
cell lines,  and expression of a construct with 115 nudeotides 
of the e promoter segment cannot be induced by IL-4 (Fig. 
3, C and D; and data not shown). Therefore, the DNA seg- 
ment residing between  -  162 and the start site of transcrip- 
tion has  one or more DNA elements required for IL-4 in- 
ducibility of the  e promoter  luciferase plasmids. 
Effects of  a Series of Linker-scanning Mutations on Expression 
of the Germline ￿9  Promoter.  Linker-scanning mutations were 
introduced into the -162/+ 53 promoter segment contained 
within  the  -162Luc reporter  plasmid in order  to identify 
DNA sequences required for IL-4 inducibility and for basal 
activity of the germline e promoter. The nudeotides affected 
by the mutations, either because of substitution or deletion, 
are shown in Fig.  2 B,  and their positions are indicated to 
the left of each sequence. 
Plasmids bearing the linker-scanning mutations were tran- 
siently transfected into  1.29#  and M12.4.1  ceU in  order  to 
test for their ability to drive luciferase expression. Each con- 
struct was tested at least three times in both cell lines.  Fig. 
3 A  shows that  most of the linker-scanning  mutations  re- 
duce basal level expression of the promoter relative to that 
obtained with the wild-type  -162Luc plasmid when trans- 
fected into 1.29# ceils, although for most mutations, the effect 
is not dramatic. The effects of the mutations differ in M12.4.1 
cells, in that nearly all mutations located 3' to  -87 abolish 
basal expression although  mutations  located 5'  to  -92  do 
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Figure  2.  (A) Sequence of 5' flank of germline e RNA and the first 
53 nucleotides  of Ie exon present  in the e promoter  - 162Luc plasmid. 
This plasmid contains  all three transcription  start  sites detected in 1.29# 
not (Fig. 3 B). These results suggest there are several DNA 
elements residing between  -136 and the start site of tran- 
scription that are necessary for normal levels of basal expres- 
sion of the germline e promoter in both cell lines, as assayed 
in the luciferase plasmid. Consistent with this is the fact that 
the nucleotide sequence between  -144 and  -14 is highly 
conserved, as it is almost identical to the sequence of the human 
germline e promoter sequence (14,  41). 
Localization of an IL-4RR  with Linker-scanning Mutations. 
The sequences in the germline ~ promoter which control in- 
duction by IL-4 appear to be much more localized than those 
required for basal expression, since only four of the linker- 
scanning mutations abolish or markedly reduce IL-4 induc- 
ibility in both 1.29/~ and M12.4.1  cells, mutant (mt) 13: at 
-120/-112, mt 20: at -106/-98, mt 27: at -87/-79, and 
mt 63:  at  -65/-39  (Fig.  3,  C  and D). 
The sequence of the - 126/- 79 segment which contains 
three of the linker-scanning mutations that abolish or reduce 
IL-4 inducibility (mrs:  13, 20,  and 27) is shown in Fig.  4 
A.  Interestingly,  these  three  mutations  altered  potential 
binding sites for three transcription factors.  Mt  13 alters a 
consensus binding site for the C/EBP family of transcription 
factors (42-45). Mt 20 alters a consensus element for a newly 
described IL-4 inducible transcription factor, NF-IL4 or IL- 
4NAF (46,  47).  Mt 27 alders a consensus binding site for 
NF-KB (48). This third mutation also abolishes constitutive 
expression. The fourth linker-scanning mutation mt 63 (- 65/ 
-38) reduces IL-4 inducibility in 1.29/~ cells by only 60% 
and basal expression by 90%, although it completely abol- 
ishes inducibility and basal expression in M12.4.1 cells. This 
mutation should abolish the binding site for the B cell-specific 
DNA binding protein BSAP, which binds to the germline 
E promoter at  -42/-15  and is required for IL-4 plus LPS 
inducibility of a CAT reporter gene driven by the mouse germ- 
line E promoter in M12.4.1 cells (13, 15). Note, however, that 
four other mutations covering the region from -55 to  -15 
also mutated the BSAP binding site, but have little or no 
effect on induction by IL-4, although they all eliminate basal 
activity in M12.4.1 (but only slightly reduce it in 1.29/~ cells). 
A  DNA Segment Containing Binding Sites for C/EBP and 
NF-IL 4 Is Su.~cient to Confer IL-4 Inducibility.  We wished 
to determine whether the DNA  sequences shown by the 
linker-scanning mutations to be necessary for IL-4 induction 
calls. The first 53-bp of the Ie exon does not have a translation  initiation 
ATG codon.  Regions indicated above the sequence are: (Flu 4RE) region 
necessary for induction of the human germline E promoter by Ib4 (14); 
(complex I & 2) a region that binds nuclear factors in B ceUs/B cell lines 
stimulated  by Ib4 (13): (complex 3) the binding site for BSAP (15, 54) 
and necessary for expression of the germline e promoter-CAT constructs 
after LPS plus  II.-4 induction (13, 15). (EPSILON CONSERVED SE. 
QUENCE) The segment is highly homologous (>80%) between human 
and mouse sequences. This sequence differs at two sites from that previ- 
ously reported  (28): at  +40/+43  we find GGGG instead  of GGG and 
at  - 15/- 19 CCCCC instead of CCCC. (B) Sequences of the  - 162Luc 
plasmids with linker  scanning  mutations.  Names are given on the left, 
followed by nucleotides that are either substituted  or deleted in the var- 
ious  mutants.  These  sequence  data  are  available from  EMBL/Gen- 
Bank/DDBJ under accession number U17387. 
185  Delphin and Stavnezer A 
O3 
X 
(n 
4~ 
r- 
,-I 
10, 
Basal expression  in 1.29~ cells 
n--3 
B  Basal expression in M12.4.1  cells 
03  *°° 1  n=3 
i 
=  T 
~,oo~  T  T 
o 
-  =.o:O  =  --:~  ... 
C 
C 
O 
1O  r- 
Io 
O 
U. 
13r 
g- 
7. 
5 
3 
1 
IL-4 induction  in 1.29~t cells 
n=3 
D 
e- 
O 
CJ 
10 
C 
m 
1O 
"6 
14. 
IL-4 induction in M12.4.1  cells 
Linker  scanning  mutations  Linker  scanning  mutations 
Figure  3.  Results of transient transfection experiments of germline e promoter-luciferase reporter plasmids having 5' deletions:  -  162Luc,  - 127Luc, 
and  -115Luc, or  -162Luc with the indicated linker scanning mutations.  (A) Basal expression in 1.29#.  Luciferase activity is reported in light units 
after subtraction of background (no cell extract) of 250-350 light units. Results are normalized to the activity of pSV2CAT which was cotransfected 
along with the luciferase plasmids. Results from three experiments plus standard deviations of the means are plotted.  (B) Basal expression in M12.4.1, 
as in A. (C) IL-4-indudble expression in 1.29/~. Transfected cells from experiments shown in A were split into two aliquots, one of which was treated 
with IL-4 for 12 h. Fold induction indicates the luciferase activity in Ib4-treated cells relative to that in untreated cells• (D) IL-4--inducible expression 
in M12.4.1,  as in C. 
of the germline e promoter are also sufficient to confer IL-4 
inducibility upon a heterologous promoter. To test this, we 
inserted a series of double-stranded oligonudeotides containing 
wild-type or mutated sequences of the IL-4RR shown in Fig. 
4 A  into a luciferase  reporter plasmid driven  by a minimal 
c-los promoter. Some of the plasmids have multiple copies 
of the oligonucleotides  in sense  and  antisense  orientations 
(indicated in Fig. 4 B). The plasmids  were transiently trans- 
fected into 1.29/~ cells,  and the cells  were stimulated with 
IL-4. Only the wild-type oligonucleotide A, which contains 
both the consensus binding  sites  for C/EBP  and  NF-IL4, 
is able to confer IL-4  inducibility upon the c-los promoter 
(Fig. 4 B).  The activity of a plasmid with one copy of the 
A oligo is induced threefold by IL-4, and plasmids with two 
or three copies are induced about 20-fold. If either the C/EBP 
or the NF-IL4 site is mutated, the plasmid is not inducible 
by IL-4.  Therefore, both sequence elements are required for 
IL-4  inducibility,  consistent with the linker-scanning  anal- 
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Figure  4.  (.4) Nucleotide sequence of the I1:4RR in the mouse germ- 
line e promoter.  Three transcription  factor binding sites are detected:  a 
C/EBP consensus element (-120/-112), the sequence defined as an NF- 
II-4 site (- 111/- 102), and a NF-IcB/p50 site (- 90/- 81). Indicated below 
the DNA sequence are the positions of the linker scanning mutations tested. 
(Flu 11,4 RE) The segment which when mutated disrupts IL-4 responsive- 
ness of human germline e promoter-CAT constructs  (14). Beneath  the 
sequence are the wild-type and mutated double stranded oligonudeotides 
that were tested for the ability to transfer IL-4 inducibility to a minimal 
c-los promoter and/or to bind to nuclear proteins in an EMSA. The muta- 
tions of the oligos are the same as those present  in the linker  scanning 
mutations.  (B) Results of transient transfection experiments in 1.29/~ cells, 
testing the I1:4 inducibility of plasmids in which the indicated oligonucle- 
otides were inserted upstream of the minimal 71-bp c-los promoter driving 
a luciferase gene. Transfection and induction conditions were as described 
above. (pFL control) The vector control, which is not inducible by II:4. 
The avenge and standard deviations of the means of five ~periments are 
plotted. The phsmids tested are indicated by, for example, pFL Awt (liner) 
which contains one copy of the wild-type A oligonucleotide. (,4trows, left) 
The orientations  of the oligonucleotide(s)  in each plasmid.  (- 162LUC) 
The wild-type germline e promoter luciferase reporter  plasmid. 
ysis, in which it was found that mutation of either of these 
sequence elements eliminates inducibility. The wild-type B 
oligo, which has the consensus KB site, does not transfer IL-4 
inducibility to the c-los promoter. Results are similar when 
the plasmids are transfected into M12.4.1 cells, although the 
induction by IL-4 is not as great as in 1.29/~ cells (data not 
shown). 
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Electrophoretic Mobility Shift Assays Demonstrate that the IL- 
4RR Does Indeed Contain Binding Sites  for NF-IL #, Ig/EBP-I, 
and NF-KB/pSO.  To determine if these consensus binding 
sites bind the predicted proteins, a series of dectrophoretic 
mobility shift assays (EMSAs) were performed using the double 
stranded oligonudeotides shown in Fig. 4 A as probes and/or 
as competitors. When wild-type oligonucleotide A  is in- 
cubated with  nuclear  extracts  from  unstimulated or  IL- 
4-treated 1.29/~ cells, a low mobility complex is induced by 
IL-4 treatment (Fig. 5 A). Competition experiments dem- 
onstrate that this complex binds to a site that matches the 
consensus sequence for a complex induced  by IL-4 (NF-IL4/IL- 
4NAF) in human monocyte and B call lines (46, 47). This 
complex is competed by wild-type oligo A, by A mt 13, and 
by oligo D, but not by mt 20, which has nucleotide substi- 
tutions in the putative NF-IL4 binding site, or by oligo E 
(Fig.  5 A).  Oligo C  does not compete (data  not shown), 
apparently because it lacks the first T  of the binding site, 
which has been shown to be important for binding of NF- 
IL4 (46). A kinetic experiment showed that the IL-4 induc- 
ible complex is detected after 30 rain of IL-4 treatment, is 
maximally induced by 4 h, and is maintained for 24 h (data 
not shown). No later time points were examined. The ki- 
netics of induction are slower and more sustained than that 
found for the binding activity in monocytes (47). 
The IL-4 inducible complex is also detected in splenic B 
cells treated with IL-4 alone for 12 h and LPS has no addi- 
tional effect (Fig. 5 C). Thus, although LPS is required for 
induction of germline e transcripts in splenic B ceils, NF-IL4 
can be induced by IL-4 alone, indicating that induction of 
NF-IL4 is not sufficient to induce transcription of the en- 
dogenous germline e RNA. 
MT 13 disrupts a consensus sequence for the C/EBP family 
of transcription factors. This family of proteins possesses a 
basic region and leucine zipper,  and all members bind the 
same DNA sequence, although not all cells have all family 
members. B cells express two members oftbe family: C/EBP3~ 
(originally called Ig/EBP-1), which is most abundant in pre- 
B cells, and C/EBP~ (also called NF-IL6, LAP, AGP/EBP, 
C1LP-2, or IL6DBP), which is expressed in mature B cell 
lines and in splenic B cells induced with LPS (45). To deter- 
mine if C/EBP family members bind the consensus C/EBP 
site, we tested binding of recombinant mouse Ig/EBP-1 (49). 
Both wild-type oligonucleotide A and mt 20 bind Ig/EBP-1, 
whereas mt 13 does not (Fig. 5 B). Thus, oligonucleotides 
with a wild-type, but not a mutated, consensus site for C/EBP 
bind Ig/EBP. The arrow on the left side of Fig. 5 A indicates 
a complex that might correspond to a C/EBP family member 
present in 1.29~,  since it is competed with both oligos A 
and mt20, but not with mt 13 or oligonucleotide D. Fur- 
thermore, this complex is competed  by a multimerized C/EBP 
binding site from the Ig ~ intron enhancer (data not shown) 
(49). However, it is not competed by oligo E, which indudes 
only the C/EBP site, suggesting that binding may require 
additional nucleotides (Fig. 5 A). We demonstrated that the 
putative KB site binds a member of the NF-KB/rel family of 
transcription factors by performing EMSAs using oligonu- 
cleotide B as a probe with nuclear extracts  from untreated Figure  5.  EMSAs  of the IL-4RR within the germline e promoter. Left-most lane in each panel or each set of lanes contains probe alone. (A) EMSA 
of oligonucleotide  A (sequence given in Fig. 4 A) incubated with 5/~g nuclear extracts from 1.29/~ cells untreated or induced for 12 h with IL-4  (+). 
Competitor oligonucleotides  were added at 100-fold  molar excess. (Arrow) A complex that appears to be due to binding at the C/EBP site (see text). 
(B) Complexes formed after incubation of recombinant Ig/EBP-I(C/EBP'y) (+) with the wild-type A oligonucleotide, with mt 13 or with mt 20. 
(C) Oligonudeotide A incubated with nuclear extracts (2/~g) from splenic B cells (Control) or splenic B cells treated with Ib4, LPS, or IL-4 plus 
LPS for 12 h. (/9) EMSAs with oligonucleotide  B demonstrate that NF-gB/pS0 binds to the wild-type B oligonucleotide. (Left) Nuclear extracts from 
untreated or Ib4-treated  1.29# cells (+) were incubated without or with the indicated oligonucleotides  as competitors. ~B is a 27-bp oligonucleotide 
containing the g enhancer gB site. (Right)  Supershift experiment using three antisera. Antiserum to NF-KB/p50 causes a supershift, but antisera for 
c-Fos and NF-KB/p65 do not (Santa Cruz Biotechnology, Santa Cruz, CA). Antisera specific  for p50 and p65 from Dr. Nancy Rice (Frederick Cancer 
Center, Frederick, MD) gave identical results (data not shown). 
or IL-4-treated  1.29#  cells,  competing with  a  DNA frag- 
ment containing the NF-KB site from the Ig K enhancer (Fig. 
5 D). Specificity of binding was also demonstrated by com- 
petition  with wild-type B  or with  mt 27,  which contains 
the mutated KB site.  All three complexes formed with oligo 
B  can be competed with  the wild-type B  oligo or with  a 
KB binding site,  but not with mt 27. In addition, when mt 
27 is labeled and used as a probe it fails to bind any complex 
(data not shown). The binding is not induced by IL-4. This 
is consistent with the finding that oligo B does not transfer 
IL-4 inducibility to the c-los promoter, although the KB site 
contributes  to the IL-4 response,  since the linker-scanning 
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Figure 6.  ComparisonofDNAsequences5'tothelexonsoflL4respon- 
sive mouse and human germline C, genes. (A) Alignment of the mouse 
and human germline e promoters to show homology between the C/EBP 
and NF-IL4 sites. (B) Alignment  of NF-IL4 and C/EBP sites in the mouse 
germline 3`1 promoter with sequences upstream of the human 3`4 switch 
region.  The C/EBP site in the 3'1 promoter has been demonstrated  to 
bind C/EBP3` and C/EBP/3 in nuclear extracts (17). The positions of the 
nucleotides from the 3`4 gene are according to the published sequence (41). 
(C) Alignment  of the C/EBP consensus sequences located at the start sites 
of transcription of the mouse germline e and 3`1 RNAs. The 3`1 sequence 
has been shown to bind C/EBP3` in nuclear extracts (17). 
mutation at this site reduces the response to IL-4 by three- 
fold in both 1.29/~ and M12.4.1 cells. Different members of 
the NF-KB/rel family differ somewhat in their DNA sequence 
requirements for binding (48). To determine which member 
of this family  binds to the putative binding site at - 90/- 81, 
we tested a series of NF-gB antisera for their effect in EMSAs 
using oligo B as the probe. An antiserum to the p50 homo- 
dimer supershifts the complex, whereas antisera to p65 or 
pSOB do not (Fig. 5 D,  right,  and data not shown). As a 
further control, we show that anti c-Fos antibody does not 
supershift the complexes. Note that linker-scanning  muta- 
tion 39, which mutates -100/-91, has no effect on expres- 
sion of the promoter in these assays, suggesting  that there 
is no additional transcription factor binding site between the 
sites for NF-IL4 and for NF-KB/p50. 
Discussion 
Results Reported Here Extend Previous Studies of the Regula- 
tion of the Ig Germline e Promoter in Mouse and Human.  The 
regulation of the mouse germline e promoter by LPS plus 
IL-4  has been previously  analyzed using a CAT reporter 
plasmid  transiently  transfected  into  M12.4.1 cells (13). 
Rothman et al. (13) found that a 5' deletion that deleted the 
C/EBP site did not reduce inducibility of their reporter gene, 
whereas we find that mutation of the C/EBP site abolishes 
induction by IL-4 when used in the absence of LPS. Further- 
more, they found that the BSAP binding site is essential for 
LPS plus IL-4 inducibility in M12.4.1 cells (15), whereas we 
find that four out of five mutations that affect the BSAP 
binding site in the promoter do not reduce IL-4 inducibility 
in either M12.4.1 or 1.29/~ cells. Thus, it is possible that in- 
duction by IL-4 alone may utilize different transcription factor 
binding sites than the combination of IL-4 plus LPS. Our 
findings agree with preliminary results on the IL-4RR of 
the promoter for the human germline e transcripts  (14). 
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Characterization of an IL-4RR  in the Germline  E Promoter. 
We have identified three transcription  factors that appear to 
regulate basal and IL-4 induction of transcription of the mouse 
germline e promoter: one or more members of the C/EBP 
family of transcription  factors, the p50 subunit  of NF-KB, 
and a newly described IL-4-inducible  transcription  factor 
termed NF-IL4 or IL-4 NAF (46, 47). We demonstrate that 
mutation of any of the sequence elements that bind these 
factors, within the context of the germline e promoter, abol- 
ishes or reduces induction by IL-4. A fragment containing 
binding sites for C/EBP and NF-IL4 is sufficient to transfer 
IL-4 inducibility  to a minimal c-los promoter,  but a frag- 
ment containing only the C/EBP consensus element or only 
the NF-IL4 element is not sufficient. The binding sites for 
these three factors and their positions relative to each other 
are conserved within the human germline e promoter. Fig. 
6 A  shows an alignment of the C/EBP and NF-IL4  con- 
sensus elements in the mouse and human germline e pro- 
moters. Furthermore, substitutions  in the C/EBP consensus 
element of the human germline e promoter eliminate IL-4 
responsiveness (14). Effects of mutations in the NF-IL4 or 
NF-KB consensus elements of the human promoter have not 
been tested. 
Consensus binding sites for the IL-4-inducible  complex 
NF-IL4/IL-4NAF have been identified in various IL-4-in- 
ducible promoters (46, 47). Although Kohler and Rieber (46) 
demonstrated that mutation of the binding site reduced the 
IL-4 inducibility of a CD23 promoter transfected  into a human 
B cell line, no evidence has been presented to indicate that 
the binding site for this factor by itself can transfer IL-4 re- 
sponsiveness to another promoter. 
Interestingly,  binding sites for C/EBP and NF-IL4  are 
also found in the promoter for mouse germline 3`1 RNA at 
about the same distance from the first RNA initiation site 
(-122/-108) as in the e promoter. The segment containing 
these binding sites is necessary for induction of the promoter- 
luciferase reporter plasmids by phorbol ester and IL-4 (16). 
Furthermore, both C/EBP~ and C/EBP3` have been shown 
to bind the C/EBP site in the germline 3`1 promoter (17). 
Unlike the e promoter,  the germline 3'1 promoter is not in- 
duced by IL-4 alone, although IL-4 synergizes with phorbol 
ester to activate this promoter. Fig. 6 B shows that in the 
3'1 promoter the C/EBP and NF-IL4 elements overlap and 
have a different position relative to each other than in the 
e promoter.  Switching to IgG4 in humans is inducible by 
IL-4, but the germline 3`4 promoter and transcription  start 
site have not been defined. These same two consensus ele- 
ments are present within an evolutionarily conserved region 
5' to the $3`4 tandem repeats, which has been postulated to 
encode the I3'4 exon and its promoter (41) (Fig. 6 B). Thus, 
it appears possible that the proteins  that bind the C/EBP 
and NF-IL4 sites interact and function together to effect IL-4 
inducibility in all four of these promoters. Although we have 
been unable to detect a complex of these factors in the EMSAs 
with oligo A, results suggestive of such an interaction  are 
shown in Fig. 5.  In Fig. 5 B it appears that the mt 20 A 
oligo binds Ig/EBP-1  less well than the wild-type A oligo, 
although the nucleotides mutated in this oligonucleotide do not  overlap the C/EBP  consensus  site.  This  suggests that 
Ig/EBP may also bind the NF-IL4 site.  This  is consistent 
with the finding in Fig.  5 A  that oligo E, which contains 
only the C/EBP  site,  does not compete with  the putative 
C/EBP complex formed with  oligo A. 
An additional C/EBP consensus element is present at the 
start site of transcription in both the mouse e and 3'1 germ- 
line promoters (17) (see Fig. 6 C). Lundgren et al. (17) have 
shown that C/EBP proteins bind at this second C/EBP site 
in the 3~1 promoter.  The second C/EBP  site  in the e pro- 
moter is located where an IL-4-inducible complex, termed 
STF-IL4,  has been shown to bind by footprinting  and by 
EMSA competition analyses (13, 50). Unlike the C/EBP sites 
located upstream in each of these promoters, no obvious con- 
sensus binding sites for NF-IL4,  as previously defined (46, 
47), are nearby. This is consistent with our finding that linker- 
scanning mutations in this region do not reduce IL-4 induc- 
ibility, although they do reduce or abolish basal activity in 
1.29# or M12.4.1  cells,  respectively. 
C/EBP~/NF-IL6 has been demonstrated to interact (via 
its leucine zipper) with RelA (NF-KB/p65) and to synergisti- 
cally activate transcription when binding the IL-8 promoter. 
By contrast,  NF-KB/pS0, when bound to the same KB site, 
had little or no ability to synergize with C/EBPfl (51, 52). 
We have been unable to detect binding of p65 to the KB site 
in the e promoter,  although  binding  of p50 is readily de- 
tected. An attractive hypothesis is that induction of NF-IL-4 
by IL-4 aids the interaction between C/EBPfl and p50, thus 
creating  an effective transcriptional  activator involving C/ 
EBPB, NF-KB/p50, and NF-IL4. Our data suggest that pS0 
may interact  with  a C/EBP protein  and/or with  NF-IL4, 
since we have shown that mutation of the KB/pS0 site reduces 
IL-4 responsiveness by threefold, although fragment B, which 
contains the loB site but not the C/EBP or NF-IL4 sites, is 
not sufficient to transfer IL-4 inducibility to a minimal c-los 
promoter. 
In conclusion, we have defined and characterized  an IL- 
4RR in the promoter for germline e RNA which is neces- 
sary for induction of the promoter by IL-4 when assayed in 
a luciferase  reporter plasmid.  This  IL-4RR is sufficient to 
transfer  IL-4  inducibility  to  another  promoter  as long  as 
binding  sites for NF-IL4 and C/EBP  transcription  factors 
are both intact.  Binding sites for these same two transcrip- 
tion factors are also closely spaced in promoters of other germ- 
line  transcripts  inducible  by IL-4.  Future  studies  will  be 
directed towards determining if these factors form a complex 
that  effects  IL-4 induction. 
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Note added in proof Since the submission of our manuscript  an additional report  on the IL-4 response 
region of the human germline e promoter which is mostly consistent with our results has been published: 
Albrecht,  B., S. Peiritsch, and M. Woisetschlager. 1994. A bifunctional control element in the human 
IgE germline promoter involved in repression and ID4 activation. Int. Immunol. 6:1143-1151. 
In addition, the protein IL-4 Stat, the eDNA for which has recently been cloned, appears to correspond 
to the complex we refer to as NF-IL4 in our manuscript.  The reference is Hou, J., U. Schindler, W. J. 
Henzel, T. C. Ho, M. Brasseur, and S. L. McKnight.  1994. An interleukin-4-induced  transcription factor: 
IL-4 Stat. Science (Wash. DC).  265:1701-1706. 
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